Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Cash & Equivalents (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Cash & Equivalents of $130.7 million for Q1 2026, up 37.01% year-over-year from $95.4 million in Q1 2025, and down 14.0% quarter-over-quarter from $152.0 million in Q4 2025.

Stevanato Group S.p.A (STVN) Cash & Equivalents (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Cash & Equivalents for 7 consecutive years, with $130.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 37.01% year-over-year to $130.7 million; the TTM figure through Mar 2026 stood at $130.7 million (up 37.01% YoY), while the FY2025 annual figure was $152.0 million, up 44.73% from the prior year.
  • Cash & Equivalents slipped to $130.7 million in Q1 2026 per STVN's latest filing, from $152.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $411.6 million in Q1 2022 and bottomed at $66.7 million in Q2 2023.
  • Historically, Cash & Equivalents has averaged $160.0 million across 5 years, with a median of $130.7 million in 2026.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 176.85% — and 2023, when it tumbled 80.16%.
  • Stevanato Group S.p.A's Cash & Equivalents stood at $233.4 million in 2022, then sank by 67.91% to $74.9 million in 2023, then surged by 40.27% to $105.0 million in 2024, then surged by 44.73% to $152.0 million in 2025, then retreated by 14.0% to $130.7 million in 2026.
  • Business Quant data shows STVN's Cash & Equivalents at $130.7 million in Q1 2026, $152.0 million in Q4 2025, and $132.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 2.76 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 708.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 1.36 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 1.47 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 2.33 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 435.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 403.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 138.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 2.15 Bn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn 91.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 91.41 Mn
Mar 31, 2026 130.74 Mn
Dec 31, 2025 152.03 Mn
Sep 30, 2025 132.49 Mn
Jun 30, 2025 106.60 Mn
Mar 31, 2025 95.42 Mn
Dec 31, 2024 105.04 Mn
Sep 30, 2024 85.66 Mn
Jun 30, 2024 84.15 Mn
Mar 31, 2024 202.42 Mn
Dec 31, 2023 74.89 Mn
Sep 30, 2023 70.56 Mn
Jun 30, 2023 66.67 Mn
Mar 31, 2023 170.41 Mn
Dec 31, 2022 233.37 Mn
Sep 30, 2022 262.08 Mn
Jun 30, 2022 336.03 Mn
Mar 31, 2022 411.55 Mn
Dec 31, 2021 470.22 Mn
Sep 30, 2021 504.70 Mn